Literature DB >> 24930567

Psychodermatological aspects of atopic dermatitis.

M S Senra1, A Wollenberg.   

Abstract

Psychodermatology is an evolving area of science that focuses on the interaction between the mind, skin and body. It is known that various neuroendocrine mediators - including adrenocorticotropin, β-endorphin, catecholamines and cortisol - are produced in response to stress. The resulting increase in endogenous glucocorticoids can disrupt the skin's barrier function, leaving it vulnerable to inflammatory disorders like atopic dermatitis (AD). In turn, AD is associated with high levels of stigmatization, social withdrawal, anxiety and depression among patients and their carers. It is well known that the stress caused by AD can make the symptoms of the disease worse. Therefore, the goal of psychodermatological treatment is not only to improve the condition of the skin, but also to teach patients/carers how to cope with the disease. This requires a multifaceted approach, and time and patience, to ascertain the needs of individual patients. A multidisciplinary team that includes a dermatologist, psychiatrist and psychologist will be necessary to deliver high-quality, tailored care to patients.
© 2014 The Authors BJD © British Association of Dermatologists.

Entities:  

Mesh:

Year:  2014        PMID: 24930567     DOI: 10.1111/bjd.13084

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  20 in total

1.  Factors Associated with Affective Symptoms and Quality of Life in Patients with Atopic Dermatitis.

Authors:  Silvia Mariel Ferrucci; Simona Tavecchio; Luisa Angileri; Teresa Surace; Emilio Berti; Massimiliano Buoli
Journal:  Acta Derm Venereol       Date:  2021-11-10       Impact factor: 3.875

Review 2.  [Dermatological diseases and their importance for psychiatry].

Authors:  P Mavrogiorgou; G Juckel
Journal:  Nervenarzt       Date:  2017-03       Impact factor: 1.214

3.  A 12-year-old girl with eczema not responding to treatment.

Authors:  Alexandra Pennal; Elena Pope
Journal:  CMAJ       Date:  2016-08-08       Impact factor: 8.262

Review 4.  Immunologic, microbial, and epithelial interactions in atopic dermatitis.

Authors:  Patrick M Brunner; Donald Y M Leung; Emma Guttman-Yassky
Journal:  Ann Allergy Asthma Immunol       Date:  2017-11-07       Impact factor: 6.347

5.  Clinical and Economic Burden of Mild-to-Moderate Atopic Dermatitis in the UK: A Propensity-Score-Matched Case-Control Study.

Authors:  Farah Toron; Maureen P Neary; Timothy W Smith; David Gruben; William Romero; Amy Cha; Keyur Patel; Simona Z Vasileva; Mahreen Ameen
Journal:  Dermatol Ther (Heidelb)       Date:  2021-04-12

6.  Reduced Venous Blood Basophil Count and Anxious Depression in Patients with Major Depressive Disorder.

Authors:  Ji Hyun Baek; Hee-Jin Kim; Maurizio Fava; David Mischoulon; George I Papakostas; Andrew Nierenberg; Jung-Yoon Heo; Hong Jin Jeon
Journal:  Psychiatry Investig       Date:  2016-05-18       Impact factor: 2.505

7.  Association of Perceived Stress with Atopic Dermatitis in Adults: A Population-Based Study in Korea.

Authors:  Hyejin Park; Kisok Kim
Journal:  Int J Environ Res Public Health       Date:  2016-07-27       Impact factor: 3.390

8.  The Association between Atopic Dermatitis and Depressive Symptoms in Korean Adults: The Fifth Korea National Health and Nutrition Examination Survey, 2007-2012.

Authors:  Sewon Kim; Jee-Yon Lee; Jin-Young Oh; Lan Chekal; Duk Chul Lee
Journal:  Korean J Fam Med       Date:  2015-11-20

9.  Psychiatry outpatient visits by atopic dermatitis patients varying in the complexity of their prescriptions: A nationwide cohort study conducted from 2005 to 2013.

Authors:  Jaeyong Shin; Young Choi; Eun-Cheol Park; Kwang Hoon Lee; Seo Young Hwang; Sang Ho Oh; Sang Gyu Lee
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

Review 10.  Association between Stress and the HPA Axis in the Atopic Dermatitis.

Authors:  Tzu-Kai Lin; Lily Zhong; Juan Luis Santiago
Journal:  Int J Mol Sci       Date:  2017-10-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.